Cargando…

Non-invasive kinetic modelling approaches for quantitative analysis of brain PET studies

Pharmacokinetic modelling with arterial sampling is the gold standard for analysing dynamic PET data of the brain. However, the invasive character of arterial sampling prevents its widespread clinical application. Several methods have been developed to avoid arterial sampling, in particular referenc...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Weijden, Chris W. J., Mossel, Pascalle, Bartels, Anna L., Dierckx, Rudi A. J. O., Luurtsema, Gert, Lammertsma, Adriaan A., Willemsen, Antoon T. M., de Vries, Erik F. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119247/ https://www.ncbi.nlm.nih.gov/pubmed/36651951 http://dx.doi.org/10.1007/s00259-022-06057-4

Ejemplares similares

Quantification of P-glycoprotein function at the human blood-brain barrier using [(18)F]MC225 and PET
por: Mossel, Pascalle, et al.
Publicado: (2023)

Evaluation of P-glycoprotein function at the blood–brain barrier using [(18)F]MC225-PET
por: Mossel, Pascalle, et al.
Publicado: (2021)

Quantitative assessment of myelin density using [(11)C]MeDAS PET in patients with multiple sclerosis: a first-in-human study
por: van der Weijden, Chris W. J., et al.
Publicado: (2022)

Long axial field of view PET scanners: a road map to implementation and new possibilities
por: Slart, Riemer H. J. A., et al.
Publicado: (2021)

Quantitative myelin imaging with MRI and PET: an overview of techniques and their validation status
por: van der Weijden, Chris W J, et al.
Publicado: (2022)

Measuring response to therapy using FDG PET: semi-quantitative and full kinetic analysis
por: Cheebsumon, Patsuree, et al.
Publicado: (2011)

Test-retest variability of quantitative [(11)C]PIB studies in Alzheimer’s disease
por: Tolboom, Nelleke, et al.
Publicado: (2009)

Evaluation of Tracer Kinetic Models for Analysis of [(18)F]FDDNP Studies
por: Yaqub, Maqsood, et al.
Publicado: (2009)

Pharmacokinetic modelling of N-(4-[(18)F]fluorobenzoyl)interleukin-2 binding to activated lymphocytes in an xenograft model of inflammation
por: Di Gialleonardo, Valentina, et al.
Publicado: (2012)

[(18)F]FDG PET in conditions associated with hyperkinetic movement disorders and ataxia: a systematic review
por: Timmers, Elze R., et al.
Publicado: (2023)

Pharmacokinetic modeling of [(11)C]flumazenil kinetics in the rat brain
por: Lopes Alves, Isadora, et al.
Publicado: (2017)

Pharmacokinetic Modeling of [(11)C]GSK-189254, PET Tracer Targeting H(3) Receptors, in Rat Brain
por: Ghazanfari, Nafiseh, et al.
Publicado: (2022)

Relationships between Serotonin Transporter Binding in the Raphe Nuclei, Basal Ganglia, and Hippocampus with Clinical Symptoms in Cervical Dystonia: A [(11)C]DASB Positron Emission Tomography Study
por: Smit, Marenka, et al.
Publicado: (2018)

Amyloid burden quantification depends on PET and MR image processing methodology
por: Kolinger, Guilherme D., et al.
Publicado: (2021)

(R)-[(11)C]Verapamil PET studies to assess changes in P-glycoprotein expression and functionality in rat blood-brain barrier after exposure to kainate-induced status epilepticus
por: Syvänen, Stina, et al.
Publicado: (2011)

Parkinson's disease-related perfusion and glucose metabolic brain patterns identified with PCASL-MRI and FDG-PET imaging
por: Teune, Laura K., et al.
Publicado: (2014)

Comparison of In Vitro Assays in Selecting Radiotracers for In Vivo P-Glycoprotein PET Imaging
por: Raaphorst, Renske M., et al.
Publicado: (2017)

PET imaging of animal models with depressive-like phenotypes
por: Vazquez-Matias, Daniel Aaron, et al.
Publicado: (2023)

Measuring serotonin synthesis: from conventional methods to PET tracers and their (pre)clinical implications
por: Visser, Anniek K. D., et al.
Publicado: (2010)

Day-to-Day Test–Retest Variability of CBF, CMRO(2), and OEF Measurements Using Dynamic (15)O PET Studies
por: Bremmer, Jochem P., et al.
Publicado: (2010)

A new approach to produce [(18)F]MC225 via one-step synthesis, a PET radiotracer for measuring P-gp function
por: Garcia-Varela, Lara, et al.
Publicado: (2021)

In Vivo Induction of P-Glycoprotein Function can be Measured with [(18)F]MC225 and PET
por: García-Varela, Lara, et al.
Publicado: (2021)

Altered Regional Cerebral Blood Flow in Chronic Whiplash Associated Disorders
por: Vállez García, David, et al.
Publicado: (2016)

Semi-quantitative cerebral blood flow parameters derived from non-invasive [(15)O]H(2)O PET studies
por: Koopman, Thomas, et al.
Publicado: (2017)

Partial volume correction strategies for quantitative FDG PET in oncology
por: Hoetjes, Nikie J., et al.
Publicado: (2010)

Binding of the Dual-Action Anti-Parkinsonian Drug AG-0029 to Dopamine D(2) and Histamine H(3) Receptors: A PET Study in Healthy Rats
por: Ghazanfari, Nafiseh, et al.
Publicado: (2022)

A proof-of-concept study on the use of a fluorescein-based (18)F-tracer for pretargeted PET
por: Helbert, Hugo, et al.
Publicado: (2022)

Test–Retest Repeatability of [(18)F]MC225-PET in Rodents: A Tracer for Imaging of P-gp Function
por: García-Varela, Lara, et al.
Publicado: (2020)

Synthesis and Evaluation of New Fluorine-18 Labeled Verapamil Analogs To Investigate the Function of P-Glycoprotein in the Blood–Brain Barrier
por: Raaphorst, Renske M., et al.
Publicado: (2017)

PET/CT imaging of Mycobacterium tuberculosis infection
por: Ankrah, Alfred O., et al.
Publicado: (2016)

Shortened duration whole body (18)F-FDG PET Patlak imaging on the Biograph Vision Quadra PET/CT using a population-averaged input function
por: van Sluis, Joyce, et al.
Publicado: (2022)

Optimization of parathyroid (11)C-choline PET protocol for localization of parathyroid adenomas in patients with primary hyperparathyroidism
por: Noltes, Milou E., et al.
Publicado: (2019)

Impact of an Adenosine A(2A) Receptor Agonist and Antagonist on Binding of the Dopamine D(2) Receptor Ligand [(11)C]raclopride in the Rodent Striatum
por: Prasad, Kavya, et al.
Publicado: (2022)

EARL compliance and imaging optimisation on the Biograph Vision Quadra PET/CT using phantom and clinical data
por: van Sluis, Joyce, et al.
Publicado: (2022)

Allosteric Interactions between Adenosine A(2A) and Dopamine D(2) Receptors in Heteromeric Complexes: Biochemical and Pharmacological Characteristics, and Opportunities for PET Imaging
por: Prasad, Kavya, et al.
Publicado: (2021)

Current and Future Use of Long Axial Field-of-View Positron Emission Tomography/Computed Tomography Scanners in Clinical Oncology
por: Roya, Mostafa, et al.
Publicado: (2023)

The Use of (18)F-FDG-PET/CT for Diagnosis and Treatment Monitoring of Inflammatory and Infectious Diseases
por: Glaudemans, Andor W. J. M., et al.
Publicado: (2013)

Effect of Dopamine D(2) Receptor Antagonists on [(18)F]-FEOBV Binding
por: Schildt, Anna, et al.
Publicado: (2020)

Extending the clinical capabilities of short- and long-lived positron-emitting radionuclides through high sensitivity PET/CT
por: van Sluis, Joyce, et al.
Publicado: (2022)

[(11)C]-DPA-713 and [(18)F]-DPA-714 as New PET Tracers for TSPO: A Comparison with [(11)C]-(R)-PK11195 in a Rat Model of Herpes Encephalitis
por: Doorduin, Janine, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_m6uec1885c2bge0hplulj4r99t